Vibration Intervention for Bone Enhancement in Childhood Cancer Survivors

描述（由申请人提供）：儿童期癌症的治疗会干扰正常的骨成熟，因此一些儿童期癌症的幸存者可能永远无法达到最大峰值骨量。在成人中，骨密度不足通常通过药物干预来解决，其长期安全性仍不确定。在儿童癌症幸存者中，目前正在进行一项随机试验，评估维生素D和钙补充剂在ALL幸存者中的有效性;然而，很少有其他干预措施可用于这一高危人群。药物干预没有考虑到骨对外部环境提供的机械刺激的反应。最近的证据表明，低幅度，高频率的机械刺激可以改善骨量和质量，可能提供一种替代或辅助药物干预的人群中，其他药物是禁忌或不接受的个人风险。有必要对这种低负担干预措施的潜力进行评估。本申请提出了一项前瞻性双盲随机临床试验，对骨矿物质密度低于其年龄和性别平均值一个或多个标准差的儿童癌症幸存者进行低幅度高频机械（LMHF）刺激。将参与者分为干预组或对照组，进行为期一年的试验。在整个试验期间，参与者将被要求每天两次站在“振动板”上10分钟。控制组的参与者将站在一个安慰剂装置上，该装置包含一个模仿振动场所声音的语音盒。如果干预组显示出骨矿物质密度（BMD）的显著改善，则将在研究结束时向对照组中的参与者提供干预。 公共卫生相关性：改善骨密度和预防早发性骨质疏松症和骨折的干预措施对于促进长寿、富有成效的生活、免于持续性疼痛和/或残疾至关重要。目前对儿童癌症幸存者BMD下降的治疗仅限于那些能够耐受药物的人，以及那些身体能力允许剧烈负重体力活动的人。这种创新的干预措施是便携式的，安全的，具有成本效益的，对癌症幸存者的负担低。它有可能单独使用或作为其他干预措施的辅助手段，以改善该风险人群的BMD。

DESCRIPTION (provided by applicant): Treatment for childhood cancer interferes with normal bone maturation such that maximal peak bone mass may never be attained by some survivors of childhood cancer. In adults, deficits in bone mineral density are usually approached via pharmacologic intervention, the long term safety of which remains uncertain. In childhood cancer survivors, a randomized trial evaluating the effectiveness of vitamin D and calcium supplementation among ALL survivors is currently underway; however, few other interventions have been offered for this at risk population. Pharmacologic interventions do not take into account the responsiveness of bone to mechanical stimuli provided by the external environment. Recent evidence demonstrates that low magnitude, high frequency mechanical stimulation can improve bone quantity and quality, perhaps providing an alternative or adjunct to pharmacologic intervention in populations where additional medications are either contraindicated or not acceptable to the individuals at risk. There is a need for an evaluation of the potential of this low burden intervention. This application proposes a prospective double blind randomized clinical trial of low magnitude, high frequency mechanical (LMHF) stimulation for childhood cancer survivors whose bone mineral density is one or more standard deviations below the mean for their age and gender. A two arm parallel allocation of participants to either the intervention or control group will be utilized for a one year trial. Participants will be asked to stand on a "vibrating plate" for 10 minutes twice per day during the entire year of the trial. Participants in the control arm will stand on a placebo device that contains a voice box that mimics the sound of the vibrating place. If the intervention arm demonstrates significant improvement in bone mineral density (BMD), participants in the control arm will be offered the intervention at the conclusion of the study. PUBLIC HEALTH RELEVANCE: Interventions to improve BMD and prevent early onset osteoporosis and fracture are essential to promote long, productive lives, free from persistent pain and/or disability. Current treatments for BMD decrements among childhood cancer survivors are limited to those who can tolerate a pharmacologic agent, and to those whose physical abilities allow a vigorous weight bearing physical activity. This innovative intervention is portable, safe, cost-effective, and of low burden to the cancer survivor. It has the potential to be used either alone or as an adjunct to other interventions to improve BMD in this at risk population.